Protein Transport Inhibitor
Protein Transport Inhibitor - Related Videos
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
0 Views •
Cited by 4 •
2015
We describe implementation of the REPLACE strategy for targeting protein-protein interactions. REPLACE is an iterative strategy involving synthetic and computational approaches for the conversion of optimized peptidic inhibitors into drug like molecules.
01:24
Protein Transport to the Stroma
0 Views •
2023
Chloroplasts are triple membrane structures with an outer membrane, an inner membrane, and a thylakoid membrane, each containing distinct metabolite transporters, membrane translocons, and enzymes. Appropriate sorting and translocating these proteins to their correct membrane systems is essential for chloroplast function. Protein complexes called the translocon of the outer chloroplast membrane or TOC complex, and the translocon of the inner chloroplast membrane or TIC complex mediate the...
01:22
Protein Transport to the Thylakoids
0 Views •
2023
Thylakoids are membrane-bound sac-like structures within the chloroplast that serve as sites for photosynthesis. Thylakoid lumen contains many electron transport proteins and is enclosed by a thylakoid membrane rich in the light-harvesting complex. Proteins targeted to the thylakoids are transported as precursors and are sorted by the general TOC/TIC import pathway. Once the precursor reaches the stroma, stromal processing peptidases remove their transit signal and expose thylakoid signal...
01:25
Inhibitors of Bacterial Protein Synthesis
0 Views •
2026
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30
Inhibitors of Viral Protein Synthesis
0 Views •
2026
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
FAQs
Different transport pathways create different experimental consequences. Inhibiting signal recognition or membrane translocation can prevent a protein from entering the route needed for its destination, whereas blocking nuclear import or export can alter where regulatory proteins accumulate. Comparing these intervention points helps researchers connect a transport defect with changes in signaling, cellular organization, or survival.
A protein's cellular location can influence whether it supports signaling, secretion, stress adaptation, or survival. Transport disruption therefore helps researchers investigate how abnormal localization contributes to tumor behavior. Tracking these location-dependent effects can clarify whether a cancer-related protein acts through its normal compartment, an altered destination, or impaired delivery to a required cellular site.
Blocking protein movement can interfere with the delivery or processing of proteins needed for cellular function. This disruption may produce endoplasmic reticulum stress, particularly when proteins cannot reach or pass through the appropriate transport route. Researchers use this response to examine whether transport dependence creates a vulnerability that shifts cancer cells from stress adaptation toward cell death.
A useful evaluation connects transport disruption with several downstream outcomes. Investigators can assess whether selected proteins change localization, then examine effects on oncogenic signaling, endoplasmic reticulum stress, and cancer-cell survival. Considering these endpoints together helps distinguish a mechanistically meaningful transport effect from an isolated change in viability without clear evidence of how the inhibitor acted.
These compounds are useful when researchers want to test whether protein trafficking supports tumor growth, abnormal signaling, secretion, or resistance to treatment. By interfering with selected transport routes, studies can reveal dependencies that may be difficult to identify through pathway analysis alone. The findings can support development and evaluation of targeted strategies directed at transport-sensitive cancer processes.
Transport pathways may help cancer cells maintain signaling, adapt to stress, or deliver proteins required for continued survival during treatment. Inhibiting those pathways allows researchers to examine whether disrupting protein movement changes resistance-associated behavior. Such experiments can identify transport processes that modify treatment response and indicate whether combining transport disruption with targeted therapy warrants further investigation.